The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Short Interest Up 290.5% in November

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) saw a large growth in short interest in the month of November. As of November 15th, there was short interest totalling 41,000 shares, a growth of 290.5% from the October 31st total of 10,500 shares. Based on an average trading volume of 26,100 shares, the short-interest ratio is currently 1.6 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Stock Up 0.6 %

Shares of NASDAQ CGABL traded up $0.11 during midday trading on Wednesday, hitting $19.25. The company had a trading volume of 8,935 shares, compared to its average volume of 22,087. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a twelve month low of $17.49 and a twelve month high of $20.85. The business has a 50-day simple moving average of $19.83 and a two-hundred day simple moving average of $19.04.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Saturday, November 15th. Shareholders of record on Saturday, November 1st will be issued a dividend of $0.2891 per share. The ex-dividend date of this dividend is Friday, October 31st. This represents a $1.16 annualized dividend and a yield of 6.01%.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Company Profile

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.